Navigation Links
'Chlamy' genome holds clues for renewable energy, the environment and human health
Date:10/11/2007

University of Minnesota researchers contributed to a national effort to sequence the genome of an ancient, one-celled organism that will help advance research in a broad range of areas, from biofuels to restoring the environment to understanding a variety of human diseases.

The organism, Chlamydomonas reinhardtii, known affectionately as Chlamy, has long fascinated scientists because it is an ancestor of plants and animals that retains characteristics of both. Like green plants, Chlamy (a type of green alga) uses photosynthesis to convert solar energy and carbon dioxide into biomass. And like many animal cells, including human sperm, it has flagella that allow it to swim.

Analysis of the 15,000 genes that make up Chlamys genome revealed hundreds that control photosynthesis and the function of flagella. The genome also provides a glimpse back through time to when all plants and animals were unicellular and used flagella to swim. When they became multicellular, plants put down roots and lost their flagella while animals retained flagella on certain kinds of cells, including sperm and cilia on some cells in the lungs, kidneys and eyes.

Led by the U.S. Department of Energys Joint Genome Institute, the University of California and the Carnegie Institute, the genome study is published in the Oct. 12 issue of Science.

Peter Lefebvre, Carolyn Silflow and Anton Sanderfoot, members of the department of plant biology faculty, were part of the national team of researchers that carried out the massive project. LeFebvre provided the DNA sample that launched the effort and Carolyn Silflow contributed a detailed molecular map that helped the team identify the function of hundreds of genes involved in photosynthesis and the formation of flagella. Students in the College of Biological Sciences also took part in the historic research.

We expect the work to produce new biological strategies for capturing solar energy, assimilating car
'/>"/>

Contact: Mark Cassutt
cassu003@umn.edu
612-624-8038
University of Minnesota
Source:Eurekalert

Page: 1 2

Related biology news :

1. Chlamydia parasite lives off our fat
2. Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia
3. Chlamydia vaccine a step closer to reality
4. Man and mouse share genome structures
5. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
6. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
7. Whole genome fine map of rice completed
8. Genome-wide mouse study yields link to human leukemia
9. Study finds more than one-third of human genome regulated by RNA
10. A bacterial genome reveals new targets to combat infectious disease
11. Scientists decipher genome of fungus that can cause life-threatening infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5, 2009 Soil is the linchpin of the environment, ... Despite that, many students see soil as "just dir... science educators are challenged with the task of...tical importance of soil in the environment. , ...science teachers at University of Nebraska-Lincoln...
(Date:11/24/2009)...itute (LRI) today named 12 new grant recipients fo...ze innovative work across a broad spectrum of lupu..., novelty, and potential to drive scientific disco...mplex disease of systemic lupus. , The 2009 gran...s across the nation and include interdisciplinary ...
(Date:11/24/2009)...an College of Medical Toxicology (ACMT) have signe...f the Journal of Medical Toxicology (JMT), the o...10. It was previously published by the University...al Toxicology , an international, peer-reviewed jo...ractice of medical toxicology. The quarterly jour...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 1Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 3LSUHSC research discovers new targets for treatment of invasive breast cancer 54910 1LSUHSC research discovers new targets for treatment of invasive breast cancer 54910 2Life Expectancy in U S Hits a New High 54906 1Life Expectancy in U S Hits a New High 54906 2Life Expectancy in U S Hits a New High 54906 3
...ying for more food at supper. Sadly, Margie Fische... at her family,s dinner table for years. Her daugh...PKU), a genetic disease that means her body can,t ... PKU is described by scientists as an autosomal re... deficiency in an enzyme called phenylalanine hydr...
...ain causes it to become asymmetrical, according to... Asymmetry in the brain is thought to be important...perate more efficiently. , Left-right asymmetry i...st evident at the time of early brain development....echanisms that bring it about. Now, in a study fun...
...through in treating premature babies at risk of de...Dr Maria Makrides from the Women,s and Children,s ... from the University of Adelaide has demonstrated ...-term infants via their mother,s breast milk or in... The findings were published today in the Journal...
Other Biology News:New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 3Game of two halves leads to brain asymmetry 2World breakthrough in treating premature babies 2
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...24 /PRNewswire-Asia/ -- Shanghai Biolaxy announced...(SFDA) has approved the,investigational new drug a...lin), an innovative insulin formulation to treat d...ate its first phase I clinical study. , D... glucose and poor,metabolism. The complications of...
(Date:11/24/2009)...ndpoint has been met for patients with advanced-st...EBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced positive efficacy data from a Phase 2 study wi...108 (formerly AN-152), in patients with advanced o...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...,ICAD), an industry-leading provider of Computer-A...tion of cancer, today announced that John,DeLucia ...ssurance and,Regulatory Affairs, reporting to iCAD...ore than 25 years of medical device, in-vitro diag... key management position. Mr.,DeLucia has signific...
...Inc. (OTC Bulletin Board: AVGO), a late stage biot...stem therapeutics for neurodegenerative,diseases, ... Administration,(FDA) and will proceed with a Phas...the treatment of Huntington,s disease, pending fin...., A double-blind, placebo-controlled Phase III c...
...dcast you,will learn about how plant biotechnology...ate stress., Climatic conditions such as heat or ...arvest turns out well or badly. Because whenever t...themselves in a stressful,situation, literally. On...farmer,s work goes far beyond the mere production ...
Other Biology Technology:iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 2iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs 3Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 2Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 3Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 4BASF Podcast - Better Harvest in Spite of Climate Stress 2BASF Podcast - Better Harvest in Spite of Climate Stress 3
Goat Anti-T7 tag Polyclonal Antibody, Agarose Conjugated from GeneTex
Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-C/EBPdelta Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: